Canada · Delayed Price · Currency is CAD ME Therapeutics Holdings Statistics
Total Valuation
CSE:METX has a market cap or net worth of CAD 147.95 million. The enterprise value is 146.32 million.
| Market Cap | 147.95M |
| Enterprise Value | 146.32M |
Important Dates
The next estimated earnings date is Thursday, November 27, 2025.
| Earnings Date | Nov 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:METX has 29.59 million shares outstanding. The number of shares has increased by 21.58% in one year.
| Current Share Class | 29.59M |
| Shares Outstanding | 29.59M |
| Shares Change (YoY) | +21.58% |
| Shares Change (QoQ) | +10.27% |
| Owned by Insiders (%) | 55.87% |
| Owned by Institutions (%) | n/a |
| Float | 13.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 80.34 |
| P/TBV Ratio | 80.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -125.40 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -155.84 |
Financial Position
The company has a current ratio of 12.23, with a Debt / Equity ratio of 0.05.
| Current Ratio | 12.23 |
| Quick Ratio | 12.01 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.09 |
| Interest Coverage | -121.18 |
Financial Efficiency
Return on equity (ROE) is -67.33% and return on invested capital (ROIC) is -42.21%.
| Return on Equity (ROE) | -67.33% |
| Return on Assets (ROA) | -40.68% |
| Return on Invested Capital (ROIC) | -42.21% |
| Return on Capital Employed (ROCE) | -64.18% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.76% in the last 52 weeks. The beta is -0.28, so CSE:METX's price volatility has been lower than the market average.
| Beta (5Y) | -0.28 |
| 52-Week Price Change | -8.76% |
| 50-Day Moving Average | 5.73 |
| 200-Day Moving Average | 5.39 |
| Relative Strength Index (RSI) | 48.54 |
| Average Volume (20 Days) | 821 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.20M |
| Pretax Income | -1.17M |
| Net Income | -1.17M |
| EBITDA | -1.18M |
| EBIT | -1.20M |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 1.71 million in cash and 85,175 in debt, giving a net cash position of 1.62 million or 0.05 per share.
| Cash & Cash Equivalents | 1.71M |
| Total Debt | 85,175 |
| Net Cash | 1.62M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 1.84M |
| Book Value Per Share | 0.06 |
| Working Capital | 1.63M |
Cash Flow
In the last 12 months, operating cash flow was -767,358 and capital expenditures -171,573, giving a free cash flow of -938,931.
| Operating Cash Flow | -767,358 |
| Capital Expenditures | -171,573 |
| Free Cash Flow | -938,931 |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:METX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.58% |
| Shareholder Yield | -21.58% |
| Earnings Yield | -0.79% |
| FCF Yield | -0.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |